Protara Therapeutics
Clinical trials sponsored by Protara Therapeutics, explained in plain language.
-
New injection could shrink painful cysts in kids without surgery
Disease control Recruiting nowThis study tests an injected medicine called TARA-002 for children aged 6 months to 18 years who have large fluid-filled cysts (lymphatic malformations). The goal is to see if up to 4 injections can safely shrink the cysts. About 38 children will take part.
Phase: PHASE2 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New injection could help intestinal failure patients avoid liver damage
Disease control Recruiting nowThis study tests a choline chloride injection in adolescents and adults with intestinal failure who need long-term nutrition through a vein. The goal is to see if the injection can safely raise choline levels and prevent liver injury. About 129 participants will receive either a …
Phase: PHASE2, PHASE3 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New bladder cancer drug shows promise in Mid-Stage trial
Disease control Recruiting nowThis study tests a new drug, TARA-002, given directly into the bladder for people with a high-grade type of bladder cancer that hasn't spread into the muscle. The goal is to see if it can make the cancer disappear. About 131 adults will take part, including those who have never h…
Phase: PHASE2 • Sponsor: Protara Therapeutics • Aim: Disease control
Last updated May 19, 2026 11:46 UTC